Tenet Healthcare valuation
Valuation
The P/E ratio is 7.68. The average price target of 22 analysts is $308.91.
Data as of November 22, 2026
Tenet Healthcare compared with similar companies
Tenet Healthcare's P/E (trailing 12 months): 7.68, −58% against the median of a group of 11 similar companies (18.4).
| Metric | Tenet Healthcare | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 7.68 | 18.4 | 14.0 – 27.7 | Low |
| Forward P/E | 12.9 | 15.2 | 13.0 – 20.1 | Low |
| EV/EBITDA | 6.96 | 11.0 | 7.87 – 16.9 | Low |
| Price/book | 3.85 | 3.85 | 3.65 – 4.90 | Middle |
| Price/sales | 0.95 | 1.33 | 1.09 – 2.82 | Low |
| Gross margin | 42.5% | 35.5% | 27.7% – 43.5% | Middle |
| Operating margin | 19.1% | 15.3% | 11.5% – 18.9% | High |
| Net margin | 13.1% | 8.1% | 7.5% – 10.3% | High |
| ROE | 41.7% | 21.1% | 17.4% – 29.1% | High |
| Debt/equity | 1.38 | 0.85 | 0.74 – 1.30 | High |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Tenet Healthcare: valuation over time
On the latest fiscal year's earnings (2025), Tenet Healthcare's P/E today is 17.0, above the median of its last 7 fiscal years (12.8; between 3.86 and 17.1 from 2018 to 2025). Relative to earnings, the stock costs more than it used to.
| Fiscal year | Price at year end | Earnings per share | P/E |
|---|---|---|---|
| 2025 | $198.72 | $15.49 | 12.8 |
| 2024 | $126.23 | $32.70 | 3.86 |
| 2023 | $75.57 | $5.71 | 13.2 |
| 2022 | $48.79 | $3.79 | 12.9 |
| 2021 | $81.69 | $8.42 | 9.70 |
| 2020 | $39.93 | $3.75 | 10.6 |
| 2019 | $38.03 | -$2.08 | — |
| 2018 | $17.14 | $1.00 | 17.1 |
| 2017 | $15.16 | -$7.00 | — |
| 2016 | $14.84 | -$1.93 | — |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- $20.95B
- Enterprise value
- $35.67B
- PEG
- 1.74
- EV/revenue
- 1.61
Profitability and growth
- ROA
- 8.7%
- ROIC
- 17.1%
- Revenue growth (year over year)
- 6.5%
- Earnings growth (year over year)
- 221.5%
Financial health
- Total cash
- $2.67B
- Total debt
- $13.24B
- Current ratio
- 1.59
- Quick ratio
- 1.28
- Altman Z-Score
- 2.06
- Piotroski F-Score
- 7.00
Dividends
- Payout ratio
- 0.0%
- Ex-dividend date
- March 13, 2000
Analysts and estimates
- Average price target
- $308.91
- Median price target
- $304.50
- High price target
- $342.00
- Low price target
- $265.00
- Analysts with a price target
- 22
- Consensus
- Buy
- Forward EPS
- $20.36
- EPS estimate, current year
- $22.53
Shares and trading
- Beta
- 1.20
- Average volume
- 804.49K
- Shares outstanding
- 79.59M
- Float
- 78.77M
- Institutional ownership
- 96.4%
- Insider ownership
- 1.0%
- Short interest (% of float)
- 2.6%
- Short ratio (days)
- 2.62
